← Back to Patent Explorer
US4851335A Expired / Lapsed US ⏱️ 0.0 years remaining

Process and reagent for the specific determination of HDL cholesterol in serum or plasma

Assignee: Roche Diagnostics GmbH
•
Filing: 1986-09-16
•
Granted: 1989-07-25
•
Expires: 2006-09-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a process for the specific determination of HDL cholesterol in serum or plasma by incubation with a cholesterol detection system, containing cholesterol oxidase and cholesterol esterase in a buffered aqueous medium, and measurement of a product of the cholesterol oxidase reaction or of the oxygen consumption, wherein a sample to be tested is incubated in the presence of a salt of a bile acid or of a bile acid derivative or of dioctylsulphosuccinate, a first measurement is then carried out, subsequently a non-ionic, polyethylene oxide group-containing detergent or a secondary alkane sulphonate is added, again incubated and a second measurement is carried out, the amount of HDL cholesterol being determined from the difference between the first and second measurement. The present invention also provides a reagent for the specific determination of HDL cholesterol in serum or plasma containing cholesterol oxidase, buffer and cholesterol esterase, wherein, referred to the final solution, it contains 0.1 to 10 U/ml. cholesterol esterase 0.05 to 10 U/ml. cholesterol oxidase 20 to 500 mmole/liter buffer substance (pH 6.0 to 8.0) 0.2 to 20 mmole/liter of a salt of a bile acid or of a bile acid derivative or of dioctylsulphosuccinate and, separately therefrom, 0.02 to 2% non-ionic polyethylene oxide group-containing detergent or secondary alkane sulphonate, and optionally 0.05 to 2% of an alcohol containing up to 3 carbon atoms.

Inventors

  • 👤 Lorenz Kerscher
  • 👤 Joachim Siedel
  • 👤 Joachim Ziegenhorn
  • 👤 Brigitte Pautz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:45
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/60; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/92

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 138 words
In a process for the specific determination of HDL cholesterol in serum or plasma sample by incubation in a reaction medium including a cholesterol detection system, containing cholesterol oxidase and cholesterol esterase in a buffered aqueous medium, followed by measurement of a product of the cholesterol oxidase reaction or of the oxygen consumption, the improvement comprising first incubating the sample to be tested with the cholesterol detecting system in the presence of a salt of a bile acid or of a bile acid derivative or of dioctylsulphosuccinate, and measuring a first amount of cholesterol, subsequently adding a non-ionic, polyethylene oxide group-containing detergent or a secondary alkane sulphonate and again incubating and measuring to determine a second amount of cholesterol, the amount of HDL cholesterol being determined from the difference between the first and second amounts of cholesterol measured.
Claim 2
Dependent Claim 138 words
In a process for the specific determination of HDL cholesterol in serum or plasma sample by incubation in a reaction medium including a cholesterol detection system, containing cholesterol oxidase and cholesterol esterase in a buffered aqueous medium, followed by measurement of a product of the cholesterol oxidase reaction or of the oxygen consumption, the improvement comprising first incubating the sample to be tested with the cholesterol detecting system in the presence of a salt of a bile acid or of a bile acid derivative or of dioctylsulphosuccinate, and measuring a first amount of cholesterol, subsequently adding a non-ionic, polyethylene oxide group-containing detergent or a secondary alkane sulphonate and again incubating and measuring to determine a second amount of cholesterol, the amount of HDL cholesterol being determined from the difference between the first and second amounts of cholesterol measured.
Claim 3
Dependent Claim 28 words
The process of claim 1, wherein the cholesterol detection system reacts with the hydrogen peroxide product of the cholesterol oxidase reaction to form a colour which is measured.
Claim 4
Dependent Claim 26 words
The process of claim 2, wherein, for the colour formation, there is used a chromogenic system containing a phenol or an aniline, 4-l -aminoantipyrine and peroxidase.
Claim 5
Dependent Claim 34 words
The process of claim 1, wherein the first incubating step is carried out in the presence of phenol or aniline and peroxidase, and the second incubation is carried out in the presence of 4-aminoantipyrine.
Claim 6
Dependent Claim 13 words
The process of claim 1 wherein cholesterol esterase from the pancreas is used.
Claim 7
Dependent Claim 27 words
The process of claim 1 wherein 0.2 to 20 mmole/liter of the salt of a bile acid or of the bile acid derivative or dioctylsulphosuccinate is used.
Claim 8
Dependent Claim 23 words
The process of claim 1 wherein 0.2 to 2% of the non-ionic polyethylene oxide group-containing detergent or the secondary alkane sulphonate is used.
Claim 9
Dependent Claim 18 words
The process of claim 1 wherein the reaction medium is at a pH of from 6.0 to 8.0.
Claim 10
Dependent Claim 28 words
The process of claim 1 wherein an alcohol containing up to 3 carbon atoms is added to the reaction medium in an amount of from 0.05 to 2%.
Claim 11
Dependent Claim 72 words
Reagent kit for the specific determination of HDL cholesterol in serum or plasma, comprising a first reagent containing cholesterol esterase, cholesterol oxidase, a buffer substance of pH 6.0 to 8.0, and a member of the group consisting of a bile acid, a bile acid derivative and dioctylsulphosuccinate; and a second reagent separated from said first reagent which contains one of a non-ionic polyethylene oxide group containing detergent or a secondary alkane sulphonate.
Claim 12
Dependent Claim 72 words
Reagent kit for the specific determination of HDL cholesterol in serum or plasma, comprising a first reagent containing cholesterol esterase, cholesterol oxidase, a buffer substance of pH 6.0 to 8.0, and a member of the group consisting of a bile acid, a bile acid derivative and dioctylsulphosuccinate; and a second reagent separated from said first reagent which contains one of a non-ionic polyethylene oxide group containing detergent or a secondary alkane sulphonate.
Claim 13
Dependent Claim 23 words
Reagent kit of claim 10, wherein said first reagent further comprises a peroxidase, and one of a phenol, a phenol derivative, or aniline.
Claim 14
Dependent Claim 17 words
Reagent kit of claim 10, wherein said second reagent further comprises a 1-3 carbon atom containing alcohol.
Claim 15
Dependent Claim 13 words
Reagent kit of claim 12, wherein said alcohol is propylene glycol or n-propanol.
Claim 16
Dependent Claim 16 words
Reagent kit of claim 10, wherein one of said first and second reagents further comprises aminoantipyrine.
Claim 17
Dependent Claim 12 words
Reagent kit of claim 10, further comprising a third reagent containing aminoantipyrine.

References Cited (Backward Citations)

US4164448A Cited
US4184921A Cited
US4226713A Cited
US4414326A Cited
US4366244A Cited
US4544630A Cited
EP0091026A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-24 1993-01-23 1993-07-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-24 1997-01-23 1997-07-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-24 2001-01-23 2001-07-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag